We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-24.42%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$137M
AUM Growth
+$14.4M
Cap. Flow
+$30.3M
Cap. Flow %
22.19%
Top 10 Hldgs %
90.6%
Holding
116
New
26
Increased
16
Reduced
32
Closed
31

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$13.7M
2
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$13.2M
3
EZGO
EZGO Technologies
EZGO
+$4.47M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.67M
5
DUO
Fangdd Network Group
DUO
+$2.19M

Top Sells

Rank Stock Value
1
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$1.71M
2
SONN
Sonnet BioTherapeutics
SONN
+$1.61M
3
SIDU icon
Sidus Space
SIDU
+$1.16M
4
ITRM
Iterum Therapeutics
ITRM
+$1.13M
5
AKTX
Akari Therapeutics
AKTX
+$741K

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.59%
2 Healthcare 7.31%
3 Consumer Discretionary 1.12%
4 Communication Services 0.83%
5 Energy 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNKK
101
Bonk Inc
BNKK
$10.2M
– –
-40,623
Closed -$597K
SIDU icon
102
Sidus Space
SIDU
$198M
– –
-64,136
Closed -$1.16M
SONN
103
DELISTED
Sonnet BioTherapeutics
SONN
– –
-18,699
Closed -$1.61M
CNTN
104
Canton Strategic Holdings
CNTN
$163M
– –
-3,534
Closed -$483K
TONX
105
TON Strategy Co
TONX
$168M
– –
-650
Closed -$140K
LFWD icon
106
ReWalk Robotics
LFWD
$20M
– –
-6,755
Closed -$340K
ATXI
107
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
– –
-7,378
Closed -$647K
BGXX
108
PUT
DELISTED
Bright Green Corporation Common Stock
BGXX
– –
-824
Closed -$83.2K
EFTR
109
PUT
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
– –
-4
Closed -$8.88K
TTOO
110
DELISTED
T2 Biosystems, Inc
TTOO
– –
-4,489
Closed -$31.7K
FUV
111
DELISTED
Arcimoto, Inc. Common Stock
FUV
– –
-24,900
Closed -$36.4K
HCDIZ
112
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
– –
-753,522
Closed -$6.41K
IONM
113
DELISTED
Assure Holdings Corp. Common Stock
IONM
– –
-7,367
Closed -$126K
OG
114
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
– –
-1,200,489
Closed -$29.8K
PBLA
115
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
– –
-11,791
Closed -$542K
1 2 3 4
5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sabby Management held 116 positions worth $137M, up 12% from $122M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management deployed $30.3M of net new capital in Q3 2023, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 77% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was BRAINSTORM CELL THERAPUTC, an estimated $1.71M trimmed.

  • Sabby Management's largest Q3 2023 buy was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.
  • Sabby Management added most to Neptune Wellness Solutions Inc. Ordinary Shares in Q3 2023, an estimated $799K increase.
  • Sabby Management's biggest Q3 2023 reduction was BRAINSTORM CELL THERAPUTC, cutting an estimated $1.71M.
  • Sabby Management fully exited Sonnet BioTherapeutics in Q3 2023, selling an estimated $1.61M.
  • Sabby Management's ten largest holdings make up 91% of its $137M portfolio in Q3 2023.
  • Sabby Management opened 26 new positions and closed 31 in Q3 2023.
  • Sabby Management's portfolio value rose 12% quarter-over-quarter to $137M.

Based on Sabby Management's 13F filing for Q3 2023, filed 14 Nov 2023.